TACR1 and head and neck squamous cell carcinoma: To evaluate the prognostic significance of TAC and TACR1 methylation and their value as biomarkers of recurrence, we examined TAC and TACR1 methylation and related to clinical features in large panels of primary HNSCC specimens [74].